Heidelberg Pharma AG

Board/Management Information • Oct 1, 2007

News Details

Ad-hoc | 1 October 2007 15:44

WILEX AG: Supervisory Board appoints Dr. Thomas Borcholte as Chief Business Officer and member of Executive Management Board of WILEX AG

WILEX AG / Change of Personnel

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

Supervisory Board appoints Dr. Thomas Borcholte as Chief Business Officer
and member of Executive Management Board of WILEX AG

Munich, 1 October 2007. The Supervisory Board of Munich-based
biopharmaceutical company WILEX AG (ISIN DE0006614720/Frankfurt Stock
Exchange/Prime Standard) today appointed Dr. Thomas Borcholte as member of
the Executive Management Board and Chief Business Officer (CBO). Dr.
Borcholte is responsible for Business Development and will implement the
Company’s commercialisation strategy. He has over 20 years experience in
leading positions in business development and marketing within the
pharmaceutical and biotechnology industries.

---

Information and Explaination of the Issuer to this News:

This communication contains certain forward-looking statements, relating to
the Company’s business, which can be identified by the use of
forward-looking terminology such as 'estimates', 'believes', 'expects',
'may', 'will' 'should' 'future', 'potential' or similar expressions or by
general discussion of strategy, plans or intentions of the Company. Such
forward-looking statements involve known and unknown risks, uncertainties
and other factors, which may cause our actual results of operations,
financial condition, performance, or achievements, or industry results, to
be materially different from any future results, performance or
achievements expressed or implied by such forward-looking statements. Given
these uncertainties, prospective investors and partners are cautioned not
to place undue reliance on such forward-looking statements. We disclaim any
obligation to update any such forward-looking statements to reflect future
events or developments.
Given these uncertainties, prospective investors and partners are cautioned
not to place undue reliance on such forward-looking statements. We disclaim
any obligation to update any such forward-looking statements to reflect
future events or developments.
01.10.2007 Financial News transmitted by DGAP

---

Language: English
Issuer: WILEX AG
Grillparzerstr. 10
81675 München
Deutschland
Phone: +49 (0)89 41 31 38 - 0
Fax: +49 (0)89 41 31 38 - 99
E-mail: info@wilex.com
Internet: www.wilex.com
ISIN: DE0006614720
WKN: 661472
Listed: Amtlicher Markt in Frankfurt (Prime Standard); Freiverkehr in
Berlin, Düsseldorf, München, Stuttgart

End of News DGAP News-Service

---